Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed S Inayat

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Virus Research|July 9, 2005
A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progressionMahboob H Qureshi, Beth A Garvy, Claire Pomeroy, et al.
Cancer Biology & Therapy|December 24, 2002
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3Mohammed S Inayat, Damodaran Chendil, Mohammed Mohiuddin, et al.
Virus Research|March 26, 2004
Basic fibroblast growth factor (bFGF) and its receptor expression (bek and flg) In bone marrow stroma of murine AIDSKam-Fai Tse, Mohammed S Inayat, Jennifer K Morrow, et al.
Virus Research|May 5, 2005
Reconstitution of erythroid, megakaryocyte and myeloid hematopoietic support function with neutralizing antibodies against IL-4 and TGFbeta1 in long-term bone marrow cultures infected with LP-BM5 murine leukemia virusKam-Fai Tse, Mohammed S Inayat, Jennifer K Morrow, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 27, 2005
Oxygen carriers: a selected reviewMohammed S Inayat, Andrew C Bernard, Vincent S Gallicchio, et al.
Journal of Inflammation (London, England)|August 20, 2010
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and TrimidoxMohammed S Inayat, Ismail S El-Amouri, Mohammad Bani-Ahmad, et al.
Antiviral Research|May 8, 2004
In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency diseaseL Ryan Sumpter, Mohammed S Inayat, Erin E Yost, et al.
Oncogene|November 7, 2002
Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2Rachael A Alcock, Swatee Dey, Damodaran Chendil, et al.
Antiviral Therapy|December 14, 2011
Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected miceVera Go, Yajarayma J Tang-Feldman, Stephanie R Lochhead, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Virus Research|July 9, 2005
A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progressionMahboob H Qureshi, Beth A Garvy, Claire Pomeroy, et al.
Cancer Biology & Therapy|December 24, 2002
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3Mohammed S Inayat, Damodaran Chendil, Mohammed Mohiuddin, et al.
Virus Research|March 26, 2004
Basic fibroblast growth factor (bFGF) and its receptor expression (bek and flg) In bone marrow stroma of murine AIDSKam-Fai Tse, Mohammed S Inayat, Jennifer K Morrow, et al.
Virus Research|May 5, 2005
Reconstitution of erythroid, megakaryocyte and myeloid hematopoietic support function with neutralizing antibodies against IL-4 and TGFbeta1 in long-term bone marrow cultures infected with LP-BM5 murine leukemia virusKam-Fai Tse, Mohammed S Inayat, Jennifer K Morrow, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 27, 2005
Oxygen carriers: a selected reviewMohammed S Inayat, Andrew C Bernard, Vincent S Gallicchio, et al.
Journal of Inflammation (London, England)|August 20, 2010
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and TrimidoxMohammed S Inayat, Ismail S El-Amouri, Mohammad Bani-Ahmad, et al.
Antiviral Research|May 8, 2004
In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency diseaseL Ryan Sumpter, Mohammed S Inayat, Erin E Yost, et al.
Oncogene|November 7, 2002
Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2Rachael A Alcock, Swatee Dey, Damodaran Chendil, et al.
Antiviral Therapy|December 14, 2011
Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected miceVera Go, Yajarayma J Tang-Feldman, Stephanie R Lochhead, et al.
Pageof 1